Peter K - Search Results

1

Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis.

Peter K, Weirich U, Nordt TK, Ruef J, Bode C. Peter K, et al. Thromb Haemost. 1999 Sep;82 Suppl 1:38-43. Thromb Haemost. 1999. PMID: 10695484 Review.

2

[Aggressive thrombolytic therapy of myocardial infarct--limits and possibilities].

Bode C, Peter K, Kübler W, Katus HA. Bode C, et al. Among authors: peter k. Z Kardiol. 1994 Jun;83(6):393-403. Z Kardiol. 1994. PMID: 8067042 Review. German.

3

A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity state.

Peter K, Bode C. Peter K, et al. Blood Coagul Fibrinolysis. 1996 Mar;7(2):233-6. doi: 10.1097/00001721-199603000-00031. Blood Coagul Fibrinolysis. 1996. PMID: 8735827

4

Patency trials with reteplase (r-PA): what do they tell us?

Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W. Bode C, et al. Among authors: peter k. Am J Cardiol. 1996 Dec 19;78(12A):16-9. doi: 10.1016/s0002-9149(96)00738-2. Am J Cardiol. 1996. PMID: 8990406 Review.

5

Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.

Nordt TK, Kornas K, Peter K, Fujii S, Sobel BE, Kübler W, Bode C. Nordt TK, et al. Among authors: peter k. Circulation. 1997 Feb 4;95(3):677-83. doi: 10.1161/01.cir.95.3.677. Circulation. 1997. PMID: 9024157

6

Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kübler W, Bode C. Peter K, et al. Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):505-12. doi: 10.1161/01.atv.17.3.505. Arterioscler Thromb Vasc Biol. 1997. PMID: 9102169

7

Clinical trial results with a new plasminogen activator.

Bode C, Peter K, Moser M, Smalling RW, Weaver WD. Bode C, et al. Among authors: peter k. Eur Heart J. 1997 Dec;18 Suppl F:F17-21. doi: 10.1093/eurheartj/18.suppl_f.17. Eur Heart J. 1997. PMID: 9447336 Review.

8

Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo.

Gries A, Bode C, Peter K, Herr A, Böhrer H, Motsch J, Martin E. Gries A, et al. Among authors: peter k. Circulation. 1998 Apr 21;97(15):1481-7. doi: 10.1161/01.cir.97.15.1481. Circulation. 1998. PMID: 9576429 Clinical Trial.

9

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

Peter K, Schwarz M, Ylänne J, Kohler B, Moser M, Nordt T, Salbach P, Kübler W, Bode C. Peter K, et al. Blood. 1998 Nov 1;92(9):3240-9. Blood. 1998. PMID: 9787160 Free article.

10

Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.

Nordt TK, Moser M, Kohler B, Ruef J, Peter K, Kübler W, Bode C. Nordt TK, et al. Among authors: peter k. Thromb Haemost. 1998 Dec;80(6):881-6. Thromb Haemost. 1998. PMID: 9869154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

953 results

Search Page

Filters